Misuse of Drugs Act 1971

Changes over time for: Paragraph 1

Version Superseded: 13/06/2012

Status:

Point in time view as at 28/03/2011.

Changes to legislation:

There are currently no known outstanding effects for the Misuse of Drugs Act 1971, Paragraph 1.

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

1U.K.The following substances, namely:—

[F2Alprazolam.]
[F3Amineptine]
[F4Aminorex]
Benzphetamine.
[F2Bromazepam.]
[F4Brotizolam]
[F5Buprenorphine]
[F2Camazepam.]
F6...
F7...
F8...
[F9Cathine.]
[F9Cathinone.]
[F2Chlordiazepoxide.]
Chlorphentermine.
[F2Clobazam.]
[F2Clorazepic acid.]
[F2Clonazepam.]
[F2Clotiazepam.]
[F2Cloxazolam.]
[F2Delorazepam.]
[F10Dextropropoxyphene.]
[F2Diazepam.]
[F11Diethylpropion.]
[F2Estazolam.]
[F2Ethchlorvynol.]
[F2Ethinamate.]
[F2Ethyl loflazepate.]
[F9Fencamfamin.]
[F9Fenethylline.]
[F9Fenproporex.]
[F2Fludiazepam.]
[F2Flunitrazepam.]
[F2Flurazepam.]
[F12Gamma–butyrolactone]
[F2Halazepam.]
[F2Haloxazolam.]
[F134-Hydroxy-n-butyric acid]
[F14Ketamine]
[F2Ketazolam.]
[F2Loprazolam.]
[F2Lorazepam.]
[F2Lormetazepam.]
[F2Mazindol.]
[F2Medazepam.]
[F9Mefenorex.]
F15. . .
Mephentermine.
[F2Meprobamate.]
[F4Mesocarb]
F16. . .
[F2Methyprylone.]
[F17Midazolam.]
[F2Nimetazepam.]
[F2Nitrazepam.]
[F2Nordazepam.]
[F2Oxazepam.]
[F2Oxazolam.]
[F18Pemoline.]
F15. . .
Phendimetrazine.
[F2Phentermine.]
[F2Pinazepam.]
F15. . .
Pipradrol.
[F2Prazepam.]
F15. . .
F19. . .
[F9Pyrovalerone.]
[F2Temazepam.]
[F2Tetrazepam.]
[F2Triazolam.]
[F9N-Ethylamphetamine.]
[F20Zolpidem]

[F21(b)[F225α–Androstane–3,17–diol.]
[F23Androst-4-ene-3,17-diol.]
[F241–Androstenediol.]
[F251–Androstenedione]
[F264-Androstene-3, 17-dione]
[F275–Androstenedione.]
[F265-Androstene-3, 17-diol]
Atamestane.
Bolandiol.
Bolasterone.
Bolazine.
Boldenone.
[F28Boldione.]
Bolenol.
Bolmantalate.
[F291,4–Butanediol.]
Calusterone.
4-Chloromethandienone.
Clostebol.
[F30Danazol.]
[F31Desoxymethyltestosterone]
Drostanolone.
Enestebol.
Epitiostanol.
Ethyloestrenol.
Fluoxymesterone.
Formebolone.
Furazabol.
[F32Gestrinone.]
[F333–Hydroxy–5α–androstan–17–one.]
Mebolazine.
Mepitiostane.
Mesabolone.
Mestanolone.
Mesterolone.
Methandienone.
Methandriol.
Methenolone.
Methyltestosterone.
Metribolone.
Mibolerone.
Nandrolone.
[F3419–Norandrostenedione.]
[F3519-Nor-4-Androstene-3, 17-dione]
[F3619–Norandrosterone.]
[F3519-Nor-5-Androstene-3, 17-diol]
Norboletone.
Norclostebol.
Norethandrolone.
[F3719–Noretiocholanolone.]
[F38Oripavine.]
Ovandrotone.
Oxabolone.
Oxandrolone.
Oxymesterone.
Oxymetholone.
Prasterone.
Propetandrol.
[F39Prostanozol]
Quinbolone.
Roxibolone.
Silandrone.
Stanolone.
Stanozolol.
Stenbolone.
Testosterone.
[F40Tetrahydrogestrinone.]
Thiomesterone.
Trenbolone.

(c)any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i)by further substitution at position 17 by a methyl or ethyl group;

(ii)by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii)by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv)by fusion of ring A with a heterocyclic system;

[F41(ca )1–benzylpiperazine or any compound structurally derived from 1–benzylpiperazine or 1–phenylpiperazine by modification in any of the following ways—

(i)by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;

(ii)by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups.]

(d)any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above F42...;